Subscribe to my YouTube Channel for a lot more: http://www.youtube.com/@BenefitWhisperer
The City of Dallas is facing rising healthcare costs and the possibility of higher costs or reduced benefits for employees.
But before making those decisions, there’s a more fundamental question:
Can the people paying the bills actually see and verify what they’re paying for?
In Part 1 of this special three-part series of The Benefit Whisperer, Ralph Weber is joined by Mark Cuban, Chris Deacon, and Marilyn Bartlett
to examine the City of Dallas health plan through the lens of claims visibility, audit rights, contract accountability, and active health-plan management.
The conversation explores:
• What does a “99% claims accuracy rate” actually measure?
• Why claim-count accuracy and claim-dollar accuracy are very different
• What Mark Cuban found after obtaining and reviewing the Dallas health-plan contract
• Whether limiting an audit to a small number of claims gives a plan meaningful oversight
• Why employers need access to their underlying claims data
• How Marilyn Bartlett approached claims, banking, and large-case management in Montana
• Why Chris Deacon believes employers must look beyond headline administrative fees and examine the actual contract terms
• Why Mark argues healthcare needs to be managed like any other major business expense
One of the central questions in this episode is simple:
Before asking employees to pay more, shouldn’t the organization funding the health plan know exactly where the money is going? This is Part 1 of 3. Part 1: What Dallas Can’t See - and Why That Matters
Part 2: What’s Buried in the Contract and Incentives
Part 3: How Dallas - and Other Employers - Take Back Control
Subscribe for Parts 2 and 3: Subscribe to my YouTube Channel and watch the video podcast!
Guests: Mark Cuban - Entrepreneur and Co-Founder of Mark Cuban Cost Plus Drug Company
Chris Deacon - Healthcare attorney and former Director of the New Jersey Division of Pensions & Benefits
Marilyn Bartlett, CPA - Nationally recognized healthcare cost-containment leader and former administrator of the Montana Employee Health Plan
Host: Ralph Weber | The Benefit Whisperer | Route Three
“This Should Be Illegal,” Mark Cuban on U.S. Healthcare (Ep. 49)
In this episode of The Benefit Whisperer, Ralph Weber sits down with Mark Cuban, David Scheinker, and Dr. Kevin Schulman to expose how healthcare pricing really works in the United States.
This is not theory.
It’s a direct look at:
Facility fees
340B program dynamics
Insurance-driven pricing
And why patients and employers rarely know what they’ll pay
At one point, Cuban compares healthcare billing to:
Charging $3 for a beer… and $5,000 for the cup.
Key Topics
Healthcare Pricing & Transparency
Why medical pricing is often unknown until after care
How contracts define process, not actual payment amounts
Insurance & Incentives
How insurers and intermediaries profit from complexity
Why delays, denials, and negotiations are built into the system
Hospital Revenue Models
The role of facility fees in cost inflation
How programs like 340B influence pricing behavior
Employer Impact
Why employers are funding the system, but lack visibility and control
The disconnect between plan design and actual outcomes
Potential Solutions
Direct contracting models
Transparent pricing strategies
Simplified, digitally defined agreements
Key Takeaway
The U.S. healthcare system is not unpredictable by accident. It’s structured in a way where complexity and lack of transparency directly support revenue generation.
Mark Cuban Founder, Cost Plus Drugs 📧 mark@costplusdrugs.com
Dr. David Scheinker Executive Director of Systems Design and Collaborative Research, Stanford Lucile Packard Children’s Hospital Founder & Director, SURF (Stanford Medicine) 🌐www.surf.stanford.edu
📧 www.linkedin.com/in/david-scheinker/
Kevin Schulman Professor of Medicine and Health Policy, Stanford University Faculty Director, Stanford Clinical Excellence Research Center 📧 kevin.schulman@stanford.edu
Produced by Kathrine Mowrey (Content & Distribution)
Money From Sick People: How PBMs Use AWP, Spread, and Rebates to Inflate Drug Costs (Ep.43)
PBMs promise big “discounts,” but what if those discounts are calculated off inflated prices? In this episode of The Benefit Whisperer, Ralph Weber interviews Antonio Ciaccia (46brooklyn Research / Three Axis Advisors) to decode the drug pricing alphabet soup, AWP, MAC, NADAC, rebates, and GPOs, and explain how incentives inside the pharmacy supply chain can drive costs up while still claiming “savings.”
Antonio shares why AWP remains the bedrock of legacy PBM contracting, how generic pricing can become a “Wild West,” and why rebates often amount to “money from sick people,” especially for members in high-deductible plans. Practical, plain-English steps for employers: understand compensation, get your full contract, and demand itemized claims data.
00:00 Unveiling the Pharmacy Benefits World
01:42 Antonio’s Journey into Drug Pricing
04:23 Understanding AWP and Its Implications
09:40 The Illusion of Discounts in Drug Pricing
13:06 The Role of PBMs in Drug Pricing
17:02 Challenges in Changing PBM Contracts
20:42 The Financial Incentives of PBMs
22:54 PBM Dysfunction in the Broader Healthcare Context
25:34 The Role of PBMs in Drug Pricing
27:57 Empowering Employers in Drug Cost Management
32:46 Decoding Drug Pricing Acronyms
36:30 The Impact of GPOs and Rebates on Drug Costs
41:44 Understanding the Burden on Patients and Employers
Ralph Weber, The Benefit Whisperer Share with a colleague. Email ralph@thebenefitwhisperer.com · (832) 924-3330 · fixmybenefitsnow.com · Schedule a free 15 minute consultation
America’s $1 Trillion Healthcare Problem: David Sheinker on How to fix it (Ep. 15)
What if the real problem with American healthcare isn’t medical but the familiar broken system that keeps your costs rising year after year? In this episode of The Benefit Whisperer, Ralph Weber sits down with Dr. David Scheinker, Founder and Director of SURF Stanford Medicine, to unpack:
Why rising costs are baked into the insurance model
How digitization, wearables, and standard contracts could finally cut the waste
What smart employers are doing now to fight back without waiting on Washington
If you’re an employer tired of paying for inefficiency and administrative games this conversation is your roadmap to do better.
👉 Watch the full episode and share it with your team.
👉 Subscribe to The Benefit Whisperer for real solutions.
👉 Book a free consultation with Ralph: https://bit.ly/3T6TUz0
👉 Follow David Sheinker’s work or get in touch: https://surf.stanford.edu/
Learn more: https://www.thebenefitwhisperer.com
00:00 Introduction to Healthcare Reform
01:23 The Vision for a Smarter Healthcare System
04:04 The Ma Bell Problem in Insurance
05:22 Insurance Profits and Healthcare Spending
06:26 The Medical Loss Ratio and Its Consequences
09:24 The Role of Competition in Healthcare
11:00 Direct Contracts and Innovative Health Plans
11:59 The Impact of TPAs and PBMs
13:02 Complexity and Transparency in Healthcare
15:33 Empowering Employers in Healthcare Decisions
17:43 Digital Medicine and Remote Patient Monitoring
19:12 Standardization in Healthcare Contracts
22:51 Medicare Advantage: Reform or Privatization?
In this episode of The Benefit Whisperer, Ralph Weber and pharmacist Benjamin Jolley delve into the complexities of prescription drug costs, focusing on how employers can navigate pharmacy benefits management (PBM) to save money. They discuss the significant savings achieved by New Jersey, the impact of drug pricing strategies, and the legal implications for employers regarding PBM contracts. The conversation emphasizes the importance of employers being proactive in managing their pharmacy benefits to avoid costly pitfalls and ensure fair pricing for medications.
Chapters
00:00 Introduction to Prescription Drug Costs
03:25 Conclusion and Future Considerations
Why Are Prescription Drugs So Expensive? The Truth About PBMs, Spread Pricing & What Employers Can Do
In this eye-opening episode of The Benefit Whisperer, host Ralph Weber sits down with pharmacist and reform advocate Benjamin Jolley to expose the hidden forces behind America’s skyrocketing prescription drug costs. 💊
From shocking stories of $1,800 bills for $140 drugs to the disturbing influence of pharmacy benefit managers (PBMs) and their spread pricing schemes, this conversation breaks down complex systems with clarity—and urgency.
🔥 Highlights include:
Why the U.S. pays more for drugs than almost any other nation
How a New Jersey benefits plan saved $1 BILLION just by rewriting its contract
The dangerous power of vertically integrated PBMs like CVS Caremark
The recent bipartisan push by 39 state Attorneys General to break up monopolies
How employers and CFOs can protect themselves from being held personally liable
If you’re an employer, benefits administrator, policymaker—or just someone wondering why your prescriptions are so expensive—this is a must-watch.
📌 Chapters: 0:00 – Welcome + Prescription Drug Teaser 0:41 – Meet Benjamin Jolley 1:00 – Why Prescription Costs Are So High 4:00 – What Is Spread Pricing? (Shocking Example) 8:00 – Silencing Critics: Non-Disparagement and Audits 13:00 – What Should Employers Be Paying Per Member? 17:40 – 39 Attorneys General Demand PBM Reform 21:00 – New Jersey’s $1B Savings by Rewriting a PBM Contract 25:00 – Closing Thoughts + How to Reach Benjamin
Subscribe to my YouTube Channel for a lot more: http://www.youtube.com/@BenefitWhisperer The City of Dallas is facing rising healthcare costs and the possibility of higher costs or reduced benefits for employees. But before making those decisions, there’s a more fundamental question: Can the people paying the bills actually see and verify what they’re paying for? In Part 1 of this special three-part series of The Benefit Whisperer, Ralph Weber is joined by Mark Cuban, Chris Deacon, and Marilyn Bartlett to examine the City of Dallas health plan through the lens of claims visibility, audit rights, contract accountability, and active health-plan management. The conversation explores: • What does a “99% claims accuracy rate” actually measure? • Why claim-count accuracy and claim-dollar accuracy are very different • What Mark Cuban found after obtaining and reviewing the Dallas health-plan contract • Whether limiting an audit to a small number of claims gives a plan meaningful oversight • Why employers need access to their underlying claims data • How Marilyn Bartlett approached claims, banking, and large-case management in Montana • Why Chris Deacon believes employers must look beyond headline administrative fees and examine the actual contract terms • Why Mark argues healthcare needs to be managed like any other major business expense One of the central questions in this episode is simple: Before asking employees to pay more, shouldn’t the organization funding the health plan know exactly where the money is going? This is Part 1 of 3. Part 1: What Dallas Can’t See - and Why That Matters Part 2: What’s Buried in the Contract and Incentives Part 3: How Dallas - and Other Employers - Take Back Control Subscribe for Parts 2 and 3: Subscribe to my YouTube Channel and watch the video podcast! Guests: Mark Cuban - Entrepreneur and Co-Founder of Mark Cuban Cost Plus Drug Company Chris Deacon - Healthcare attorney and former Director of the New Jersey Division of Pensions & Benefits Marilyn Bartlett, CPA - Nationally recognized healthcare cost-containment leader and former administrator of the Montana Employee Health Plan Host: Ralph Weber | The Benefit Whisperer | Route Three
